EnClear Therapies
Latest round
- Series A
Last raised
- Feb 2020
Total raised
- $12M
Investors
- 9
About EnClear Therapies
Founded in 2018 and based in Massachusetts, US, EnClear Therapies, Inc. develops a device-based treatment to remove toxic protein buildup in cerebrospinal fluids that cause neurodegeneration in patients suffering from Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), and Progressive Supranuclear Palsy (PSP). In September 2024, EnClear Therapies, Inc. The company specializes in addressing the challenge of delivering therapeutics across barriers like the blood-brain barrier (BBB), blood-cSF, and blood-arachnoid barriers. The firm’s core technology, the EnTrega CSF Platform, is designed to deliver therapeutics to targeted areas within the CNS through the cerebrospinal fluid (CSF). This method allows for controlled, continuous, and personalized delivery, which optimizes dosage, increases therapeutic efficacy, and minimizes the risk of peripheral toxicity and severe side effects. In addition, the company’s platform facilitates easy access to CSF for monitoring and diagnostics. The firm’s partners include Amgen, Thiel, Quark Venture, Sanford Biosciences, Bioverge, and others.
Who invested in EnClear Therapies
9 investors across 2 rounds
See all investors in EnClear Therapies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EnClear Therapies
Who invested in EnClear Therapies?
EnClear Therapies has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EnClear Therapies raised?
EnClear Therapies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did EnClear Therapies last raise money?
EnClear Therapies's most recent round on record is a Series A, in Feb 2020.
What does EnClear Therapies do?
Founded in 2018 and based in Massachusetts, US, EnClear Therapies, Inc.
Where is EnClear Therapies headquartered?
EnClear Therapies is headquartered in Newburyport, US.
Which VCs invest in companies like EnClear Therapies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at EnClear Therapies's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like EnClear Therapies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.